Historical Drug Costs among Elderly Patients Hospitalized with Heart Failure in Canada, 2013/14–2018/19

Figures

• 

  Figure 1. Study patient flow diagram. CIHI, Canadian Institute for Health Information; DAD, Discharge Abstract Database; Dx, diagnoses; FY, fiscal year; HF, heart failure; NPDUIS, National Prescription Drug Utilization Information System.

• 

  Central Illustration. Rising drug costs in elderly patients hospitalized with heart failure in Canada from 2013–2014 to 2018–2019. $s are CAD$. GDMT, guideline-directed medical therapy; M, million; pts, patients; QC, Quebec; NS, Nova Scotia.

• 

  Figure 2. (A) Guideline-directed medical therapy (GDMT) and diuretics cost composition of total heart failure (HF) drug costs stratified by fiscal year for the elderly hospitalized HF patients. (B) Average cost of HF drugs per patient and the total number of patients receiving drugs by fiscal year for elderly hospitalized HF patients. $s are given in $CAD. HF, heart failure; M, million.

• 

  Figure 3. Annual guideline-directed medical therapy (GDMT) composition of total heart failure (HF) drug costs for elderly hospitalized HF patients stratified by: (A) province; Y-axis truncated from 60% to 90% to enhance visualization of differences; (B) age groups (bottom line gives age ranges [Y]); and (C) sex. AB, Alberta; BC, British Columbia; MB, Manitoba; NB, New Brunswick; NL, Newfoundland; ON, Ontario; PE, Prince Edward Island; SK, Saskatchewan.